AI-Powered Research

Discover powerful insights with advanced AI analysis tools for clinical trials.

Learn more →

Premium Access

Get unlimited access to our comprehensive pharmaceutical database and analytics.

Karolinska Institutet

🇧🇪Belgium

Country: 🇧🇪Belgium

Ownership: Private

Established: 1810-01-01

Employees: 1K

Market Cap: -

Website: http://www.ki.se

Clinical Trials

Internet Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)

Not Applicable

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Behavioral: Internet CBT

First Posted Date: 2011-05-05

Last Posted Date: 2018-03-21

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 23

Registration Number: NCT01348529

Locations: 🇸🇪
Internetpsykatrienheten, M46, Psykiatri sydväst, Stockholm, Sweden

Internet-based Cognitive Behavior Therapy (CBT) for Obsessive Compulsive Disorder (OCD)

Phase 2

Completed

Conditions: Obsessive Compulsive Disorder

Interventions: Behavioral: Support therapy on Internet
Behavioral: Internet-based cognitive behavior therapy

First Posted Date: 2011-05-04

Last Posted Date: 2018-03-21

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 101

Registration Number: NCT01347099

Locations: 🇸🇪
Psykiatri Sydväst, Stockholm, Sweden

Study of Omega-3 Fatty Acids Regarding Ergogenic, Anti-inflammatory and Obesity Inhibitory Effects in 8 Year Old Children

Not Applicable

Completed

Conditions: Overweight and Obesity
Essential Fatty Acid Deficiency
Lifestyle-related Condition

Interventions: Dietary Supplement: Omega-3
Dietary Supplement: Placebo

First Posted Date: 2011-03-25

Last Posted Date: 2018-10-05

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 423

Registration Number: NCT01323283

Locations: 🇸🇪
Karolinska Universitetssjukhuset, Huddinge, Södermanland, Sweden

Prospective Intervention Study on Vitamin D in Patients With Cystic Fibrosis

Not Applicable

Completed

Conditions: Cystic Fibrosis

Interventions: Dietary Supplement: Supplementation with vitamin D2/D3

First Posted Date: 2011-03-24

Last Posted Date: 2024-10-15

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 16

Registration Number: NCT01321905

Locations: 🇸🇪
Stockholm Cystic Fibrosis Center, Karolinska University Hospital Huddinge, Stockholm, Sweden

Abatacept Treatment in Polymyositis and Dermatomyositis

Phase 2

Completed

Conditions: Polymyositis
Dermatomyositis

Interventions: Drug: Abatacept Active Treatment
Drug: Abatacept Delayed-Onset Treatment

First Posted Date: 2011-03-16

Last Posted Date: 2020-11-06

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 20

Registration Number: NCT01315938

Locations: 🇨🇿
Institute of Rheumatology, Prague, Czechia
🇸🇪
Karolinska University Hospital, Stockholm, Sweden

Optimal Time to Initiate Antiretroviral Therapy in HIV & TB Coinfected Adults Being Treated for Tuberculosis

Not Applicable

Conditions: Acquired Immunodeficiency Syndrome
Tuberculosis

Interventions: Other: Comparison of different treatment strategies

First Posted Date: 2011-03-15

Last Posted Date: 2011-03-15

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 450

Registration Number: NCT01315301

Locations: 🇪🇹
Tikur Anbessa (Black Lion) Hospital, Addis Ababa, Ethiopia

Effects of Yoga on Objective and Self-reported Health Indicators Among Female and Male Individuals

Not Applicable

Completed

Conditions: Stress, Psychological, Physiological

Interventions: Other: Yoga intervention

First Posted Date: 2011-02-28

Last Posted Date: 2014-10-24

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 44

Registration Number: NCT01305096

Locations: 🇸🇪
Karolinska Institute, Stockholm, Sweden

School Intervention With Daily Physical Activity and Healthy Food for Students With an Intellectual Disability.

Not Applicable

Completed

Conditions: Weight Loss
Mental Retardation
Food Habits

Interventions: Behavioral: Healthier, Smarter, Happier

First Posted Date: 2011-02-08

Last Posted Date: 2011-02-08

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 145

Registration Number: NCT01291238

Locations: 🇸🇪
Karolinska Institutet, Department of clinical science, intervention and technology. Division of pediatrics, B62, Stockholm, Sweden

Basal Analog Study - Comparison of Lantus or Levemir With NPH Insulin From T1DM Diagnosis

Phase 4

Conditions: Diabetes Mellitus Type 1

Interventions: Drug: NPH insulin
Drug: Glargine
Drug: Detemir

First Posted Date: 2011-01-06

Last Posted Date: 2011-01-06

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 120

Registration Number: NCT01271517

Locations: 🇸🇪
Division of Pediatrics, Karolinska University Hospital, Stockholm, Sweden

Nordic Adjuvant IFN Melanoma Trial

Phase 3

Completed

Conditions: Melanoma
Adjuvant Therapy

Interventions: Drug: Interferon-alpha2b - 1 year
Drug: Interferon-alpha2b - 2 years

First Posted Date: 2010-12-14

Last Posted Date: 2010-12-14

Lead Sponsor: Karolinska Institutet

Target Recruit Count: 855

Registration Number: NCT01259934

Locations: 🇸🇪
Karolinska Institutet, Karolinska University Hospital,, Stockholm, Sweden

Home Terms & Conditions Privacy Policy